The improvement of living standards has led more and more people to pay attention to physical health, and people are increasingly interested in disease prevention. Entrepreneurship in the field of preventive medicine is optimistic. Many start-up companies are looking for suitable investors and hope to open up a market in the field of preventive medicine. CareSkore smells the opportunity and looks at the preventive medicine market.
Founded in 2014, CareSkore graduated from the Y Combinator incubator and currently employs 15 people. Today, the company announced a $4.5 million seed round of financing. Investors include Storm ventures, Cota Capital, Rising Tide Fund and Liquid 2 Ventures. The purpose of this round of financing is to bring machine learning into medical preventive care.
Headquartered in Mountain View, Calif., CareSkore combines clinical, socioeconomic, demographic, and behavioral data to create a complete trend chart for patients so doctors and insurance companies can use the chart. To provide patients with better preventive medical care.
CareSkore's platform can alert doctors to patients who may miss an appointment and who are likely to forget to take their medication on time. In addition to the risk of death, the platform examines the patient's chart with the hospital and the doctor's office to analyze the patient's risk of re-admission, falls, and infectious disease. Doctors can use this information to guide their work, proactively contact patients, give patients advice and additional services.
If new risk factors arise, patients will receive personalized text messages or calls that prompt them to take action. CareSkore provides specific templates for specific diseases such as chronic obstructive pulmonary disease to provide health advice to patients. Patients can also use this system to inform their doctor about their new symptoms and ask questions about their condition.
Shanghai Rocatti Biotechnology Co., Ltd. is a professional enterprise of rehabilitation and medical device products with sales and service as the main body. Since its establishment, the company has been committed to the development of medical devices. Its products involve the production of epidemic prevention materials such as gynecology (obstetrics), Urology, neurosurgery, kn95 medical protective masks, daily use flat masks, and the research and development of total nutrition slimming food. It can provide a complete range of first, second and third class medical device configuration schemes for general hospitals and specialized hospitals.
Nonwoven Face Mask,Non-Woven Facial Face Mask,Non-Woven Face Mask Ffp2,Non-Woven Surgical Face Mask
Shanghai Rocatti Biotechnology Co.,Ltd , https://www.shljdmedical.com